Joint Position Statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on Routine Testing for Latent Tuberculosis Infection Prior To and During Treatment of Psoriasis Patients with IL-17 or IL-23 Inhibitors
作者
Andrew Blauvelt,Bruce E Strober,Guy S Eakin,Leah McCormick Howard,Christy Langan,Peter C.M. van de Kerkhof,Lluís Puig,Mark G Lebwohl,Ricardo Romiti,April W. Armstrong,Siew Eng Choon,Ravi Ramessur,Joel M. Gelfand,Joseph F. Merola,Kevin L. Winthrop,Tiago Torres